Xtl Biopharmaceuticals Ltd Stock Price Transform Weighted Close Price

XTLB Stock  USD 1.95  0.04  2.09%   
XTL Biopharmaceutica price transform tool provides the execution environment for running the Weighted Close Price transformation and other technical functions against XTL Biopharmaceutica. XTL Biopharmaceutica value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of price transform indicators. As with most other technical indicators, the Weighted Close Price transformation function is designed to identify and follow existing trends. XTL Biopharmaceutica price transformation methods enable investors to generate trading signals using basic price transformation functions such as typical price movement.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Developed by Larry Williams, the Weighted Close is the average of XTL Biopharmaceuticals high, low and close of a chart with the close values weighted twice. It can be used to smooth an indicator that normally takes only XTL Biopharmaceutica closing price as input.

XTL Biopharmaceutica Technical Analysis Modules

Most technical analysis of XTL Biopharmaceutica help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for XTL from various momentum indicators to cycle indicators. When you analyze XTL charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About XTL Biopharmaceutica Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of XTL Biopharmaceuticals Ltd. We use our internally-developed statistical techniques to arrive at the intrinsic value of XTL Biopharmaceuticals Ltd based on widely used predictive technical indicators. In general, we focus on analyzing XTL Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build XTL Biopharmaceutica's daily price indicators and compare them against related drivers, such as price transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of XTL Biopharmaceutica's intrinsic value. In addition to deriving basic predictive indicators for XTL Biopharmaceutica, we also check how macroeconomic factors affect XTL Biopharmaceutica price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Days Sales Outstanding22.3321.21
PTB Ratio2.32.41
Hype
Prediction
LowEstimatedHigh
0.091.868.63
Details
Intrinsic
Valuation
LowRealHigh
0.081.648.41
Details
Naive
Forecast
LowNextHigh
0.041.828.60
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.821.871.91
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether XTL Biopharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of XTL Biopharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xtl Biopharmaceuticals Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xtl Biopharmaceuticals Ltd Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XTL Biopharmaceuticals Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XTL Biopharmaceutica. If investors know XTL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XTL Biopharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Earnings Share
(0.03)
Return On Assets
(0.14)
Return On Equity
(0.13)
The market value of XTL Biopharmaceuticals is measured differently than its book value, which is the value of XTL that is recorded on the company's balance sheet. Investors also form their own opinion of XTL Biopharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is XTL Biopharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XTL Biopharmaceutica's market value can be influenced by many factors that don't directly affect XTL Biopharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XTL Biopharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if XTL Biopharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XTL Biopharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.